Management of thrombosis in antiphospholipid antibody syndrome

Research output: Contribution to journalArticle

Abstract

Antiphospholipid antibody positive patients are at risk for venous and arterial thrombosis. The risk of recurrent thromboembolism is high. Although the standard of care is high intensity warfarin after a thromboembolic event, some studies indicate that this degree of anticoagulation is not needed. There is an urgent need of clinical trials to address management of thrombosis in antiphospholipid syndrome.

Original languageEnglish (US)
Pages (from-to)633-642
Number of pages10
JournalRheumatic Disease Clinics of North America
Volume27
Issue number3
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Management of thrombosis in antiphospholipid antibody syndrome'. Together they form a unique fingerprint.

  • Cite this